4//SEC Filing
Ribeill Yves J 4
Accession 0001615594-23-000037
CIK 0001705843other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 7:23 PM ET
Size
16.4 KB
Accession
0001615594-23-000037
Insider Transaction Report
Form 4
Cibus, Inc.CLXT
Ribeill Yves J
Director
Transactions
- Award
Stock Option (Right-to-Buy)
2023-03-01+25,000→ 25,000 totalExercise: $4.55Exp: 2030-08-04→ Common Stock (25,000 underlying) - Disposition to Issuer
Stock Option (Right-to-Buy)
2023-03-01−25,000→ 0 totalExercise: $4.55Exp: 2030-08-04→ Common Stock (25,000 underlying) - Disposition to Issuer
Stock Option (Right-to-Buy)
2023-03-01−10,291→ 0 totalExercise: $4.22Exp: 2031-05-27→ Common Stock (10,291 underlying) - Disposition to Issuer
Stock Option (Right-to-Buy)
2023-03-01−47,200→ 0 totalExercise: $0.30Exp: 2032-06-13→ Common Stock (47,200 underlying) - Award
Stock Option (Right-to-Buy)
2023-03-01+47,200→ 47,200 totalExercise: $0.30Exp: 2032-06-13→ Common Stock (47,200 underlying) - Award
Stock Option (Right-to-Buy)
2023-03-01+10,291→ 10,291 totalExercise: $4.22Exp: 2031-05-27→ Common Stock (10,291 underlying)
Footnotes (1)
- [F1]Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.
Documents
Issuer
Cibus, Inc.
CIK 0001705843
Entity typeother
Related Parties
1- filerCIK 0001604049
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 7:23 PM ET
- Size
- 16.4 KB